Svelte Medical Systems Inc

FDA Filings

This page includes the latest FDA filings for Svelte Medical Systems Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)

FDA Filings

Device Company	Device	Date
PMA P210014 Svelte Medical Systems, Inc.	SLENDER Sirolimus-Eluting Coronary Stent Integrated Delivery System and DIRECT Sirolimus-Eluting Coronary Stent Rapid Ex	2021-12-13

Similar & Related FDA Registered Companies

Svelte Medical Systems, Inc.675 Central Avenue, Suite 2new Providence, NJ 07974 PMA NumberP210014 Supplement NumberS001 Date Received01/12/2022 Decision Date04/08/2022 Product Code NIQ Advisory Committee Cardiovascular Supplement Typenormal 180 Day Track No User Fee Supplement Reason Postapproval Study Protocol Expedited Review Granted? No

Related Finance Registrations

SEC

0001396555

SVELTE MEDICAL SYSTEMS INC of DELAWARE